Count | |
| 2 | |
| 2 | |
| 1 | |
| 79 | |
| 47 | |
| 1 | |
| 4 | |
| 4 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 3 | |
| 4 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
Superantigens/genetics/immunology/metabolism/*therapeutic use | 1 |
| 1 | |
| 1 | |
| 1 | |
| 45 | |
| 5 | |
| 4 | |
| 7 | |
| 4 | |
| 28 | |
| 1 | |
| 3 | |
| 2 | |
| 6 | |
| 2 | |
| 2 | |
| 1 | |
| 25 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Blood Group Incompatibility/*blood/immunology/*prevention & control | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 13 | |
| 13 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 4 | |
| 1 | |
| 12 | |
| 1 | |
| 2 | |
| 3 | |